Experience of entecavir in renal graft recipients with chronic hepatitis B
Aim of investigation. To estimate efficacy and safety of entecavir (ETV) in chronic hepatitis B (CHB) at renal graft recipients (RGR).Material and methods. Four RGR with CHB on in mean 71,5±36,9 month after kidney transplantation received treatment by entecavir. In 2 patients with CHB biochemical re...
Saved in:
Main Authors: | M. L. Zubkin, Ye. P. Sel'kova, F. K. Kokoyeva, T. A. Semenenko, V. I. Chervinko, A. N. Kolomoyets, E. M. Balakirev, A. V. Frolov, T. P. Nekrasova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2011-09-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1450 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis
by: Lu Cao, et al.
Published: (2025-01-01) -
Chronic glomerulonephritis of the mixed type in patient with HBV-infection (<i>Clinical case</i>)
by: V. S. Adonyeva, et al.
Published: (2013-07-01) -
Entecavir: stability and drug-excipient compatibility
by: Ariadne Botto Fiorot, et al.
Published: (2025-01-01) -
Efficacy of hepatitis B vaccination in patients awaiting liver transplantation in prophylaxis of <i>de novo</i> HBV-infection of a graft
by: V. Ye. Syutkin, et al.
Published: (2010-04-01) -
Current Views of Torque Teno Virus (TTV) in Liver Diseases
by: I. V. Maev, et al.
Published: (2020-09-01)